Recently
Microchip Technology, Inc.
(
MCHP
) declared the inclusion of its latest SST11CP16 5 GHz power
amplifier (PA) in its product profile. With the addition of the
newest PA in its product line, the company has expanded its RF
portfolio.
The newly launched product is particularly designed for
supporting IEEE 802.11ac ultra high data rate Wi-Fi standard system
in a minimized Error Vector Magnitude (EVM). In addition, it offers
low operating current to enhance the transmission range for a high
data rate.
The SST11CP16 PA is appropriate for various applications of
set-top boxes, routers, access points and Wi-Fi devices, which
require data rates of 3Gbps. In addition, PA has an input and
output match and a linear power detector. Microchip's advanced
state-of-the-art technologies would allow for low power consumption
and highly productive amplifiers.
Microchip develops and manufacturers microcontrollers, memory
and analog and interface products for embedded control systems,
which are small, low-power computers designed to perform specific
tasks. The company's revenues declined 6% annually to $352.1
million for the first quarter of fiscal 2013. However, management
expects net sales between $412 million and $430 million in the
second quarter of fiscal 2013, up 17% - 22% sequentially.
Microchip competes against significantly larger companies with
greater financial resources, such as
Freescale Semiconductor, Ltd.
(
FSL
) and Renesas Electronics Corporation. New market entrants are also
increasingly targeting embedded control applications, which could
negatively impact the company's financial performance in the
future.
The current Zacks Consensus Estimates for the second quarter of
fiscal 2013 and for fiscal 2013 are 47 cents per share and $1.90
per share, respectively. The company currently retains a Zacks #1
Rank, which translates into a short-term 'Strong Buy' rating. We
also have a 'Neutral' recommendation on the company's stock.
FREESCALE SEMI (FSL): Free Stock Analysis
Report
MICROCHIP TECH (MCHP): Free Stock Analysis
Report
To read this article on Zacks.com click here.
Zacks Investment
Research